News
Asianet Newsable on MSN4h
Replimune Stock Catches Retail Fire As Analyst Says FDA Shakeup Removes 'Major Obstacle' For Skin Cancer Drug's Potential Approval
Analysts believe the resignation of a top FDA official could lead to a reversal of the melanoma drug rejection, which was ...
Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...
TipRanks on MSN9h
Sarepta Stock (SRPT) Rallies on FDA Nod for Broader Gene Therapy Use
Shares of Sarepta Therapeutics ($SRPT) jumped over 14% on Tuesday after the FDA authorized the company to restart shipments ...
Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure. A ...
A new opioid threat you probably haven't heard about is targeting kids. Products containing 7-OH are currently being sold ...
Gas station heroin” took another hit on Wednesday as HHS Secretary Robert F. Kennedy Jr’s FDA recommended a scheduling action ...
After our editorial, the agency relents to allow a Duchenne treatment.
Take a trip down the candy aisle of memory lane with these sweet treats banned, pulled, or lost to the sugar-coated past.
INDIANA- The U.S. Food and Drug Administration today is taking a bold step to protect Americans from dangerous, illegal ...
Food and Drug Administrator Commissioner Marty Makary has requested that the Drug Enforcement Administration classify 7-OH as ...
A public health alert has been issued for certain ham salads containing Food and Drug Administration (FDA) regulated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback